Patents by Inventor Tyson MOYER

Tyson MOYER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230330219
    Abstract: Compositions containing a nucleic acid nanostructure having a desired geometric shape and immunostimulatory agent(s) bound to its surface are provided. The nanostructures can be, for example, in the form of a 6-helix bundle, or icosahedron, or a pentagonal bipyramid. The nanostructure design allows for control of the relative position and/or stoichiometry of the immunostimulatory agent(s) bound to its surface. The immunostimulatory agent(s) displayed on the nanostructure surface are arranged with the preferred number, spacing, and 3D organization to elicit a robust immune response. The displayed antigen can be a TLR agonist, such as a TLR9 agonist. The immunostimulatory compositions may thus be useful as immunogens, vaccines, adjuvants, and the like. Methods of inducing immune responses, and for targeted induction of TLR activation are also provided.
    Type: Application
    Filed: August 11, 2022
    Publication date: October 19, 2023
    Inventors: Mark Bathe, Remi Veneziano, Eike-Christian Wamhoff, Tyson Moyer, Benjamin Joseph Read, Rebecca Du, Darrell Irvine
  • Publication number: 20230302128
    Abstract: The present disclosure provides immunomodulatory fusion proteins-metal hydroxide complexes comprising an immunomodulatory domain adsorbed to a metal hydroxide via ligand exchange. The disclosure also features compositions and methods of using the same, for example, to treat cancer.
    Type: Application
    Filed: February 22, 2023
    Publication date: September 28, 2023
    Inventors: Darrell J. IRVINE, Karl Dane Wittrup, Tyson Moyer, Yash Agarwal
  • Patent number: 11642409
    Abstract: The present disclosure provides immunomodulatory fusion proteins-metal hydroxide complexes comprising an immunomodulatory domain adsorbed to a metal hydroxide via ligand exchange. The disclosure also features compositions and methods of using the same, for example, to treat cancer.
    Type: Grant
    Filed: April 24, 2020
    Date of Patent: May 9, 2023
    Assignee: Massachusetts Insttute of Technology
    Inventors: Darrell J. Irvine, Karl Dane Wittrup, Tyson Moyer, Yash Agarwal
  • Patent number: 11419932
    Abstract: Compositions containing a nucleic acid nanostructure having a desired geometric shape and antigens bound to its surface are provided. The nanostructures can be, for example, in the form of a 6-helix bundle or icosahedron. The nanostructure design allows for control of the relative position and/or stoichiometry of the antigen bound to its surface. The antigens displayed on the nanostructure surface are arranged with the preferred number, spacing, and 3D organization to elicit a robust immune response. The displayed antigen can be an HIV immunogen such as eOD-GT6, eOD-GT8, or variants thereof. The compositions may thus be useful as immunogens, vaccines, immunostimulators, adjuvants, and the like. Methods of inducing immune responses, inducing protective immunity, inducing the production of neutralizing antibodies or inhibitory antibodies, inducing tolerance, and treating cancer, infectious or autoimmune diseases are also provided.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: August 23, 2022
    Assignee: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
    Inventors: Mark Bathe, Remi Veneziano, Eike-Christian Wamhoff, Tyson Moyer, Benjamin Joseph Read, Darrell Irvine
  • Patent number: 11224648
    Abstract: The present disclosure relates to compositions and methods for coupling an antigen to an adjuvant, immunogenic compositions and vaccines. The methods of the invention can be used to increase an immune response, or to treat cancer or an infectious disease.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: January 18, 2022
    Assignees: Massachusetts Institute of Technology, The Scripps Research Institute
    Inventors: Darrell J. Irvine, Tyson Moyer, William R. Schief
  • Publication number: 20200405850
    Abstract: The present disclosure provides immunomodulatory fusion proteins-metal hydroxide complexes comprising an immunomodulatory domain adsorbed to a metal hydroxide via ligand exchange. The disclosure also features compositions and methods of using the same, for example, to treat cancer.
    Type: Application
    Filed: April 24, 2020
    Publication date: December 31, 2020
    Applicant: Massachusetts Institute of Technology
    Inventors: Darrell J. IRVINE, Karl Dane WITTRUP, Tyson MOYER, Yash AGARWAL
  • Publication number: 20200237903
    Abstract: Compositions containing a nucleic acid nanostructure having a desired geometric shape and antigens bound to its surface are provided. The nanostructures can be, for example, in the form of a 6-helix bundle or icosahedron. The nanostructure design allows for control of the relative position and/or stoichiometry of the antigen bound to its surface. The antigens displayed on the nanostructure surface are arranged with the preferred number, spacing, and 3D organization to elicit a robust immune response. The displayed antigen can be an HIV immunogen such as eOD-GT6, eOD-GT8, or variants thereof. The compositions may thus be useful as immunogens, vaccines, immunostimulators, adjuvants, and the like. Methods of inducing immune responses, inducing protective immunity, inducing the production of neutralizing antibodies or inhibitory antibodies, inducing tolerance, and treating cancer, infectious or autoimmune diseases are also provided.
    Type: Application
    Filed: January 24, 2020
    Publication date: July 30, 2020
    Inventors: Mark Bathe, Remi Veneziano, Eike-Christian Wamhoff, Tyson Moyer, Benjamin Joseph Read, Darrell Irvine
  • Publication number: 20190358312
    Abstract: The present disclosure relates to compositions and methods for coupling an antigen to an adjuvant, immunogenic compositions and vaccines. The methods of the invention can be used to increase an immune response, or to treat cancer or an infectious disease.
    Type: Application
    Filed: December 19, 2018
    Publication date: November 28, 2019
    Inventors: Darrell J. IRVINE, Tyson MOYER, William R. SCHIEF